The biotech sector is witnessing unprecedented scientific breakthroughs that were once deemed unattainable. Industry veteran Jeremy Levin highlights the progress being made in this field.
However, Levin warns that American leadership in biotechnology may be at risk. This concern stems from various factors, including the roles of regulators, investors, and public institutions that support these innovations.
As the industry continues to evolve, it is crucial to address these leadership challenges to ensure that the United States remains at the forefront of biotech advancements.